Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study

​ Conditions: Breast Cancer Interventions: Drug: Cyclin-dependent Kinase 4/6 Inhibitor Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Active, not recruiting Conditions: Breast Cancer Interventions: Drug: Cyclin-dependent Kinase 4/6 Inhibitor...